Chicoric acid prevents methotrexate hepatotoxicity via attenuation of oxidative stress and inflammation and up-regulation of PPARγ and Nrf2/HO-1 signaling

Environ Sci Pollut Res Int. 2020 Jun;27(17):20725-20735. doi: 10.1007/s11356-020-08557-y. Epub 2020 Apr 3.

Abstract

Chicoric acid (CA) is a natural antioxidant with promising hepatoprotective activity. We investigated the potential of CA to prevent methotrexate (MTX) hepatotoxicity, pointing to the role of Nrf2/HO-1 signaling and PPARγ. Rats received CA for 15 days and were then injected with MTX at day 16. Blood and tissue samples were collected for analysis at day 19. CA ameliorated liver function markers and mitigated histological alterations in MTX-induced rats. Pre-treatment with CA suppressed reactive oxygen species and lipid peroxidation and enhanced antioxidants in MTX-induced rats. Moreover, CA upregulated hepatic Nrf2, HO-1, NQO-1, and PPARγ, and attenuated inflammation. Consequently, CA inhibited apoptosis by increasing Bcl-2 expression and suppressing Bax, cytochrome c, and caspase-3 in MTX-administered rats. In conclusion, CA prevented oxidative stress, inflammation, and liver injury induced by MTX by activating Nrf2 /HO-1 signaling and PPARγ.

Keywords: Chicoric acid; Hepatotoxicity; Methotrexate; Nrf2; Oxidative stress; PPARγ.

MeSH terms

  • Animals
  • Antioxidants
  • Caffeic Acids*
  • Chemical and Drug Induced Liver Injury*
  • Inflammation
  • Liver
  • Methotrexate
  • NF-E2-Related Factor 2*
  • Oxidative Stress / drug effects
  • PPAR gamma* / genetics
  • Rats
  • Rats, Wistar
  • Succinates
  • Up-Regulation / drug effects

Substances

  • Antioxidants
  • Caffeic Acids
  • NF-E2-Related Factor 2
  • PPAR gamma
  • Succinates
  • chicoric acid
  • Methotrexate